EUVIMEDEUVIMED entdecken
Crossref

Immunogenicity of novel DNA vaccines encoding receptor‐binding domain (RBD) dimer‐Fc fusing antigens derived from different SARS‐CoV‐2 variants of concern

Ting Zhang iD, Zhirong Wang, Jiaojiao Yang, Xuemei Xu

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Ting Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics and Structural Biology, School of Basic Medicine Peking Union Medical College, Institute of Basic Medical Sciences Chinese A…. Hauptthemen laut MEDLINE: COVID-19, Vaccines, DNA, COVID-19 Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continuously emerging of severe acute respiratory syndrome coronavirus‐2 variants of concern (VOCs) led to a decline in effectiveness of the first‐generation vaccines. Therefore, optimized vaccines and vaccination strategies, which show advantages in protecting against VOCs, are urgently needed. Here we constructed an optimized DNA vaccine plasmid containing built‐in CpG adjuvant, and designed vaccine candidates encoding five forms of antigens derived from Wuhan‐Hu‐1. The results showed that plasmid with receptor binding domain (RBD) dimer‐Fc fusing antigen (2RBD‐Fc) induced the highest level of RBD‐specific IgG and neutralizing antibodies in mice. Then 2dRBD‐Fc and 2omRBD‐Fc vaccines, respectively derived from delta and omicron VOCs, were constructed. The 2dRBD‐Fc induced potent humoral and cellular immune responses, while the immunogenicity of 2omRBD‐Fc was low. We also observed that sequential immunization with 2RBD‐Fc, 2dRBD‐Fc and 2omRBD‐Fc effectively elicited neutralizing antibodies against each immunized strain, and RBD‐specific T cell responses. To be noted, the Wuhan‐Hu‐1, delta and omicron neutralizing antibody titers induced by sequential immunization were comparable to that induced by repetitive immunization with 2RBD‐Fc, 2dRBD‐Fc or 2omRBD‐Fc respectively. The results suggest that sequential immunization with DNA vaccines encoding potent antigens derived from different VOCs, may be a promising strategy to elicit immune responses against multiple variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Vaccines, DNACOVID-19 VaccinesAnimalsHumansMiceAntibodies, NeutralizingAntibodies, ViralSARS-CoV-2Spike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

DNA vaccineRBDSARS-CoV-2sequential immunization

Substanzen

Antibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Vaccines, DNACOVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Biophysics and Structural Biology, School of Basic Medicine Peking Union Medical College, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Ting Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, T., Wang, Z., Yang, J., & Xu, X. (2023). Immunogenicity of novel DNA vaccines encoding receptor‐binding domain (RBD) dimer‐Fc fusing antigens derived from different SARS‐CoV‐2 variants of concern. Journal of Medical Virology. https://doi.org/10.1002/jmv.28563

Vancouver

Zhang T, Wang Z, Yang J, Xu X. Immunogenicity of novel DNA vaccines encoding receptor‐binding domain (RBD) dimer‐Fc fusing antigens derived from different SARS‐CoV‐2 variants of concern. Journal of Medical Virology. 2023. doi:10.1002/jmv.28563

BibTeX
@article{Zhang2023,
  author = {Zhang, Ting and Wang, Zhirong and Yang, Jiaojiao and Xu, Xuemei},
  title = {Immunogenicity of novel DNA vaccines encoding receptor‐binding domain (RBD) dimer‐Fc fusing antigens derived from different SARS‐CoV‐2 variants of concern},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28563}
}
Kostenlos starten →